***************************************************************************************************
Please click on a link below to go
directly to that vote:
COMMITTEE_VOTE (RCS# 0028) THIRD_READING (RCS# 0145)
***************************************************************************************************
OKLAHOMA HOUSE OF
REPRESENTATIVES
First Regular
Session
59th Oklahoma
Legislature
HB2065 Pediatric cancer; creating the
Pediatric Cancer
Martinez Research and Resources Revolving
Fund; utilization
THIRD PASSED
READING
YEAS:
100
RCS# 145
NAYS: 0
03/08/2023
EXC :
1
02:17 PM
C/P : 0
145
YEAS:
100
Alonso-Sandoval Ford May Sims
Archer Fugate Maynard Smith
Baker Gann McBride Sneed
Banning George McDugle Staires
Bashore Goodwin McEntire Stark
Bennett Grego Menz Steagall
Blancett Hardin Miller Sterling
Boatman Hasenbeck Moore Stinson
Boles Hefner Munson Strom
Burns Hilbert Newton Swope
Caldwell (C) Hill Nichols Talley
Caldwell (T) Humphrey ODonnell Tedford
Cantrell Johns Olsen Townley
Conley Kane Osburn Turner
Cornwell Kannady Pae Vancuren
Crosswhite Hader Kendrix Patzkowsky Waldron
Culver Kerbs Pfeiffer Wallace
Davis Lawson Pittman West (J)
Deck Lepak Provenzano West (K)
Dempsey Lowe (D) Randleman West (R)
Dobrinski Lowe (J) Ranson West (T)
Dollens Luttrell Roberts Williams
Duel Manger Roe Wolfley
Echols Marti Rosecrants Worthen
Fetgatter Martinez Schreiber Mr. Speaker
NAYS:
0
EXCUSED:
1
Hays
CONSTITUTIONAL PRIVILEGE: 0
***************************************************************************************************
Appropriations and Budget
Committee
2023-24
HB2065 Public health and
safety; Public Health
Hardin and Safety Reform
Act of 2023; effective
date.
DO PASS AS AMENDED BY CS PASSED
YEAS:
31
RCS# 28
NAYS: 0
2/22/2023
C/P : 0 07:29:32 PM
YEAS:
31
Bashore Bennett Blancett Boatman
Boles Fetgatter Ford Goodwin
Hasenbeck Hilbert Hill Kannady
Kendrix Kerbs Lawson Lowe (D)
Luttrell Martinez McEntire Miller
Moore Munson Newton Nichols
O'Donnell Pfeiffer Provenzano Ranson
Strom Vancuren Wallace
NAYS:
0
CONSTITUTIONAL PRIVILEGE: 0
***************************************************************************************************